ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2462

Higher Number of Tender Than Swollen Joint Count Is Associated to Higher Patient Reported Outcomes and Composite Scores As Well As Reduced Probability of Obtaining Remission: Results from a One-Year Follow-up Study of Established RA Patients Starting Bdmards

Hilde Berner Hammer1,2, Till Uhlig1, Tore K. Kvien1,2 and Jon Lampa3, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Dep of Medicine, Rheumatology unit, Karolinska Institute, Karolinska Institute, Stockholm, Sweden

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: remission and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  The swollen and tender joint count is included in composite scores (DAS28, CDAI, SDAI, ACR/EULAR Boolean remission). Low swollen/tender joint ratio (STR) has been found to be associated with reduced clinical response[1]. Ultrasound (US), including grey scale (GS) synovitis and power Doppler (PD) assessment of vascularity is sensitive for detecting inflammatory activity. Presently we explored associations between STR and pain catastrophizing, PROs, composite scores, clinical evaluation and US assessments, and more importantly, with composite score remission, in a follow-up study of established RA patients initiating bDMARDs.

Methods: 209 patients with RA (mean (SD) age 53 (13) years, disease duration 10 (9) years, 81% women, 79% anti-CCP positive) were included when initiating bDMARDs and assessed at baseline and after 1, 2, 3, 6 and 12 months with PROs (joint pain VAS, patient’s global VAS, RAID score and MHAQ), clinical examinations (assessor’s disease activity VAS, tender and swollen joint counts (of 28)) and laboratory variables (ESR and CRP). STRs were calculated with insertion of 1 if 0 in the denominator. Pain catastrophizing was assessed by two questions from the Coping Strategies Questionnaire. All US examinations (semi-quantitative scoring (0-3)) of GS and PD (PIP 2-3, MCP 1-5, wrist (RC, IC, RU), elbow, knee, tibiotalar, MTP 1-5 and ext.carpi ulnaris/tib.post.tendons bilaterally) were performed by one rheumatologist (HBH) (Siemens Acuson Antares, excellence version, 5-13 MHz probe). Statistical calculations included Pearson’s correlations, independent samples T-test and cross-tabs for assessing risk levels.

Results: There was a wide distribution of STR levels (median 1.0 (IQR 0.6-2.5), mean (SD) 2.4 (3.8)). During follow-up there were no/low cross-sectional correlations between STR and all the PROs and laboratory markers (r= -0.03-0.24), but moderate to high correlations with assessor’s global (r= 0.27-0.42, p<0.001) and the US examinations (GS; r=0.48-0.63/PD; r=0.38-0.67, p<0.001). Patients were divided into groups with STR ≥ 1.0 or <1.0. The table (including mean values) shows that patients with STR<1.0 during follow-up had significantly higher levels of PROs and composite scores but lower US scores. Patients with STR < 1.0 achieved less often remission according to the composite scores (STR<1.0/STR≥1; DAS28 4.3%/36.4% and 3.3%/35.5%, CDAI 2.7%/17.9% and 1.3%/23.7%, SDAI 3.3%/20.1% and 3.3%/24.3%/, Boolean 2.7%/18.5% and 1.3%/21.7% at 6 and 12 months, respectively).

Conclusion: Established RA patients with higher number of tender than swollen joint count had higher levels of PROs and composite scores, but lower US pathology, and more importantly, lower achievement of clinical remission. Thus, these patients may have a trait including higher subjective scores, which is relevant within the treat-to-target strategy. Reference: Kristensen LE et al, Arthritis Care Res 2014 Feb;66(2):173-9


Disclosure: H. B. Hammer, None; T. Uhlig, None; T. K. Kvien, None; J. Lampa, None.

To cite this abstract in AMA style:

Hammer HB, Uhlig T, Kvien TK, Lampa J. Higher Number of Tender Than Swollen Joint Count Is Associated to Higher Patient Reported Outcomes and Composite Scores As Well As Reduced Probability of Obtaining Remission: Results from a One-Year Follow-up Study of Established RA Patients Starting Bdmards [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/higher-number-of-tender-than-swollen-joint-count-is-associated-to-higher-patient-reported-outcomes-and-composite-scores-as-well-as-reduced-probability-of-obtaining-remission-results-from-a-one-year-f/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/higher-number-of-tender-than-swollen-joint-count-is-associated-to-higher-patient-reported-outcomes-and-composite-scores-as-well-as-reduced-probability-of-obtaining-remission-results-from-a-one-year-f/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology